Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece.

Touloumi G, Kalpourtzi N, Papastamopoulos V, Paparizos V, Adamis G, Antoniadou A, Chini M, Karakosta A, Makrilakis K, Gavana M, Vantarakis A, Psichogiou M, Metallidis S, Sipsas NV, Sambatakou H, Hadjichristodoulou C, Voulgari PV, Chrysos G, Gogos C, Chlouverakis G, Tripsianis G, Alamanos Y, Stergiou G; AMACS and EMENO.

PLoS One. 2020 Mar 30;15(3):e0230730. doi: 10.1371/journal.pone.0230730. eCollection 2020.

2.

Treatment strategies are more important than drugs in the management of rheumatoid arthritis.

Drosos AA, Pelechas E, Voulgari PV.

Clin Rheumatol. 2020 Feb 22. doi: 10.1007/s10067-020-05001-x. [Epub ahead of print] Review.

PMID:
32088801
3.

Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis.

Pelechas E, Voulgari PV, Drosos AA.

Ther Clin Risk Manag. 2019 Sep 4;15:1073-1079. doi: 10.2147/TCRM.S167452. eCollection 2019.

4.

Reply to the Editor.

Kaltsonoudis E, Pelechas E, Voulgari PV, Drosos AA.

Semin Arthritis Rheum. 2020 Apr;50(2):e7. doi: 10.1016/j.semarthrit.2019.07.005. Epub 2019 Aug 1. No abstract available.

PMID:
31466838
5.

Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry.

Papadopoulos CG, Gartzonikas IK, Pappa TK, Markatseli TE, Migkos MP, Voulgari PV, Drosos AA.

Rheumatol Adv Pract. 2019 Mar 14;3(1):rkz007. doi: 10.1093/rap/rkz007. eCollection 2019.

6.

Rheumatoid Arthritis Treatment. A Back to the Drawing Board Project or High Expectations for Low Unmet Needs?

Drosos AA, Pelechas E, Voulgari PV.

J Clin Med. 2019 Aug 16;8(8). pii: E1237. doi: 10.3390/jcm8081237.

7.

Successful treatment with rituximab of IgG4-related disease coexisting with adult-onset asthma and periocular xanthogranuloma.

Asproudis I, Kanari M, Ntountas I, Ragos V, Goussia A, Batistatou A, Voulgari PV.

Rheumatol Int. 2020 Apr;40(4):671-677. doi: 10.1007/s00296-019-04409-2. Epub 2019 Aug 7. Review.

PMID:
31392499
8.

Maintained Clinical Remission in Ankylosing Spondylitis Patients Switched from Reference Infliximab to Its Biosimilar: An 18-Month Comparative Open-Label Study.

Kaltsonoudis E, Pelechas E, Voulgari PV, Drosos AA.

J Clin Med. 2019 Jul 2;8(7). pii: E956. doi: 10.3390/jcm8070956.

9.

Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study.

Tsirves GK, Voulgari PV, Pelechas E, Asimakopoulos AD, Drosos AA.

Eur Arch Otorhinolaryngol. 2019 Sep;276(9):2419-2426. doi: 10.1007/s00405-019-05487-5. Epub 2019 May 30.

PMID:
31175453
10.

Comment on: Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry.

Kaltsonoudis E, Pelechas E, Voulgari PV, Drosos AA.

Rheumatology (Oxford). 2019 Oct 1;58(10):1883-1884. doi: 10.1093/rheumatology/kez206. No abstract available.

PMID:
31170297
11.

Conventional radiography of the hands and wrists in rheumatoid arthritis. What a rheumatologist should know and how to interpret the radiological findings.

Drosos AA, Pelechas E, Voulgari PV.

Rheumatol Int. 2019 Aug;39(8):1331-1341. doi: 10.1007/s00296-019-04326-4. Epub 2019 May 22. Review.

PMID:
31119369
12.

The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital.

Kaltsonoudis E, Pelechas E, Papoudou-Bai A, Markatseli TE, Elisaf M, Voulgari PV, Drosos AA.

PLoS One. 2019 Mar 29;14(3):e0210845. doi: 10.1371/journal.pone.0210845. eCollection 2019.

13.

Golimumab for Rheumatoid Arthritis.

Pelechas E, Voulgari PV, Drosos AA.

J Clin Med. 2019 Mar 20;8(3). pii: E387. doi: 10.3390/jcm8030387. Review.

14.

Unmet needs in the treatment of ankylosing spondylitis: a long-term observational study from a single university center.

Pelechas E, Kaltsonoudis E, Voulgari PV, Drosos AA.

Rheumatol Int. 2019 Apr;39(4):663-668. doi: 10.1007/s00296-019-04277-w. Epub 2019 Mar 15.

PMID:
30877371
15.

National Survey of Morbidity and Risk Factors (EMENO): Protocol for a Health Examination Survey Representative of the Adult Greek Population.

Touloumi G, Karakatsani A, Karakosta A, Sofianopoulou E, Koustenis P, Gavana M, Alamanos Y, Kantzanou M, Konstantakopoulos G, Chryssochoou X, Benos A, Vantarakis A, Hadjichristodoulou C, Chlouverakis G, Trypsianis G, Voulgari PV, Makrilakis K, Liatis S, Stergiou G; EMENO Study Group.

JMIR Res Protoc. 2019 Feb 4;8(2):e10997. doi: 10.2196/10997.

16.

Granuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based review.

Pelechas E, Papoudou-Bai A, Voulgari PV, Drosos AA.

Rheumatol Int. 2019 Feb;39(2):353-357. doi: 10.1007/s00296-018-4212-0. Epub 2018 Dec 7. Review.

PMID:
30523477
17.

Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study.

Panopoulos S, Tektonidou M, Drosos AA, Liossis SN, Dimitroulas T, Garyfallos A, Sakkas L, Boumpas D, Voulgari PV, Daoussis D, Thomas K, Georgiopoulos G, Vosvotekas G, Vassilopoulos D, Sfikakis PP.

Arthritis Res Ther. 2018 Dec 4;20(1):267. doi: 10.1186/s13075-018-1771-0.

18.

Liver perivascular epithelioid cell tumor in a patient with systemic lupus erythematosus.

Voulgari PV, Tatsi V, Milionis HJ, Goussia A, Xydis V, Glantzounis GK.

Int J Surg Case Rep. 2018;53:193-195. doi: 10.1016/j.ijscr.2018.10.063. Epub 2018 Nov 1.

19.

Epidemiological characteristics of psoriatic arthritis.

Migkos MP, Somarakis GP, Markatseli TE, Voulgari PV, Drosos AA.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):324-332. Epub 2018 Oct 8. Review.

PMID:
30299245
20.

Image Gallery: Capillaroscopy for noninvasive scabies diagnosis.

Gaitanis G, Voulgari PV, Bassukas ID.

Br J Dermatol. 2018 Sep;179(3):e133. doi: 10.1111/bjd.16729. No abstract available.

PMID:
30222885
21.

Unmet needs in the treatment of rheumatoid arthritis. An observational study and a real-life experience from a single university center.

Kaltsonoudis E, Pelechas E, Voulgari PV, Drosos AA.

Semin Arthritis Rheum. 2019 Feb;48(4):597-602. doi: 10.1016/j.semarthrit.2018.06.003. Epub 2018 Jun 22.

PMID:
30075990
22.

Five-year prospective multi-center cohort study of patients with giant cell arteritis in Greece.

Tsalapaki C, Nikitopoulou E, Boki KA, Boumpas D, Sfikakis PP, Vosvotekas G, Voulgari PV, Vassilopoulos D.

Mediterr J Rheumatol. 2018 Jun 29;29(2):103-105. doi: 10.31138/mjr.29.2.103. eCollection 2018 Jun.

23.

Sjögren Syndrome Associated with Inflammatory Muscle Diseases.

Migkos MP, Sarmas I, Somarakis GA, Voulgari PV, Tsamis KI, Drosos AA.

Mediterr J Rheumatol. 2018 Jun 29;29(2):92-96. doi: 10.31138/mjr.29.2.92. eCollection 2018 Jun.

24.

An Extensive Study of the Functional Polymorphisms of Kinin-Kallikrein System in Rheumatoid Arthritis Susceptibility.

Chatzikyriakidou A, Voulgari PV, Drosos AA.

Arch Rheumatol. 2017 Sep 13;33(1):33-38. doi: 10.5606/ArchRheumatol.2018.6389. eCollection 2018 Mar.

25.

Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence.

Flouri ID, Markatseli TE, Boki KA, Papadopoulos I, Skopouli FN, Voulgari PV, Settas L, Zisopoulos D, Iliopoulos A, Geborek P, Drosos AA, Boumpas DT, Sidiropoulos P.

J Rheumatol. 2018 Jun;45(6):785-794. doi: 10.3899/jrheum.170477. Epub 2018 Apr 1.

26.

An uncommon presentation of Granulomatosis with Polyangiitis.

Pelechas E, Zouzos G, Voulgari PV, Drosos AA.

Mediterr J Rheumatol. 2018 Mar 19;29(1):49-51. doi: 10.31138/mjr.29.1.49. eCollection 2018 Mar.

27.

ABP 501 for the treatment of rheumatoid arthritis.

Pelechas E, Voulgari PV, Drosos AA.

Expert Opin Biol Ther. 2018 Mar;18(3):317-322. doi: 10.1080/14712598.2018.1430760. Epub 2018 Jan 24. Review.

PMID:
29350566
28.

High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients.

Thomas K, Flouri I, Repa A, Fragiadaki K, Sfikakis PP, Koutsianas C, Kaltsonoudis E, Voulgari PV, Drosos AA, Petrikkou E, Sidiropoulos P, Vassilopoulos D.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):254-262. Epub 2017 Nov 9.

PMID:
29148406
29.

A Case of Recalcitrant Psoriatic Arthritis to TNF Inhibitors Improved After Administration of Secukinumab, an IL-17A Inhibitor.

Pelechas E, Memi T, Voulgari PV, Drosos AA.

Rheumatol Ther. 2017 Dec;4(2):509-513. doi: 10.1007/s40744-017-0084-0. Epub 2017 Oct 11.

30.

Changes in the cytokine profile in first-episode, drug-naïve patients with psychosis after short-term antipsychotic treatment.

Petrikis P, Voulgari PV, Tzallas AT, Boumba VA, Archimandriti DT, Zambetas D, Papadopoulos I, Tsoulos I, Skapinakis P, Mavreas V.

Psychiatry Res. 2017 Oct;256:378-383. doi: 10.1016/j.psychres.2017.07.002. Epub 2017 Jul 3.

PMID:
28688350
31.

Uncommon presentation of granulomatosis with polyangiitis in association with subclinical coeliac disease.

Voulgari PV, Apostolou F, Dounousi E, Liapis G, Elisaf M, Drosos AA.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):160. Epub 2017 Jun 9. No abstract available.

PMID:
28598778
32.

Sirukumab: a promising therapy for rheumatoid arthritis.

Pelechas E, Voulgari PV, Drosos AA.

Expert Opin Biol Ther. 2017 Jun;17(6):755-763. doi: 10.1080/14712598.2017.1315099. Epub 2017 Apr 10.

PMID:
28374627
33.

Transfusion-related acute lung injury in a patient with systemic lupus erythematosus.

Pelechas E, Gerolymatou N, Voulgari PV, Drosos AA.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):353. Epub 2017 Jan 27. No abstract available.

PMID:
28134082
34.

Elevated levels of Insulin-like Growth Factor-1 (IGF-1) in drug-naïve patients with psychosis.

Petrikis P, Boumba VA, Tzallas AT, Voulgari PV, Archimandriti DT, Skapinakis P, Mavreas V.

Psychiatry Res. 2016 Dec 30;246:348-352. doi: 10.1016/j.psychres.2016.09.053. Epub 2016 Sep 28.

PMID:
27764741
35.

Joint complaints correlate with increased serum IgE levels in patients hospitalized for moderate-to-severe psoriasis: A single center retrospective study.

Voulgari PV, Gaitanis G, Fidhi L, Migkos MP, Bassukas ID.

J Am Acad Dermatol. 2016 May;74(5):1014-5.e4. doi: 10.1016/j.jaad.2015.11.026. No abstract available.

PMID:
27085234
36.

Impaired Antiatherogenic Functions of High-density Lipoprotein in Patients with Ankylosing Spondylitis.

Gkolfinopoulou C, Stratikos E, Theofilatos D, Kardassis D, Voulgari PV, Drosos AA, Chroni A.

J Rheumatol. 2015 Sep;42(9):1652-60. doi: 10.3899/jrheum.141532. Epub 2015 Aug 1.

PMID:
26233507
37.

Cytokine profile in drug-naïve, first episode patients with psychosis.

Petrikis P, Voulgari PV, Tzallas AT, Archimandriti DT, Skapinakis P, Mavreas V.

J Psychosom Res. 2015 Oct;79(4):324-7. doi: 10.1016/j.jpsychores.2015.06.011. Epub 2015 Jul 17.

PMID:
26213351
38.

Tuberculous pyomyositis in a rheumatoid arthritis patient treated with anakinra.

Migkos MP, Somarakis GA, Markatseli TE, Matthaiou M, Kosta P, Voulgari PV, Drosos AA.

Clin Exp Rheumatol. 2015 Sep-Oct;33(5):734-6. Epub 2015 May 1.

PMID:
25936426
39.

Counting Costs under Severe Financial Constraints: A Cost-of-Illness Analysis of Spondyloarthropathies in a Tertiary Hospital in Greece.

Tsifetaki N, Migkos MP, Papagoras C, Voulgari PV, Athanasakis K, Drosos AA.

J Rheumatol. 2015 Jun;42(6):963-7. doi: 10.3899/jrheum.141277. Epub 2015 Apr 1.

PMID:
25834213
40.

Golimumab, the newest TNF-α blocker, comes of age.

Papagoras C, Voulgari PV, Drosos AA.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):570-7. Epub 2015 Jan 20. Review.

PMID:
25602858
41.

Evidence of ERBB3 gene association with rheumatoid arthritis predisposition.

Chatzikyriakidou A, Voulgari PV, Drosos AA.

Int J Rheum Dis. 2016 Feb;19(2):146-9. doi: 10.1111/1756-185X.12514. Epub 2014 Dec 20.

PMID:
25530448
42.

Sense of coherence and self-sacrificing defense style as predictors of psychological distress and quality of life in rheumatoid arthritis: a 5-year prospective study.

Goulia P, Voulgari PV, Tsifetaki N, Andreoulakis E, Drosos AA, Carvalho AF, Hyphantis T.

Rheumatol Int. 2015 Apr;35(4):691-700. doi: 10.1007/s00296-014-3134-8. Epub 2014 Sep 21.

PMID:
25240430
43.

Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review.

Kotsis K, Voulgari PV, Drosos AA, Carvalho AF, Hyphantis T.

Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):857-72. doi: 10.1586/14737167.2014.957679. Epub 2014 Sep 5. Review.

PMID:
25193010
44.

Non-HLA genes in ankylosing spondylitis: what meta-analyses have shown?

Chatzikyriakidou A, Voulgari PV, Drosos AA.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):735-9. Epub 2014 Jul 28. Review.

PMID:
25068597
45.

Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study.

Kaltsonoudis E, Zikou AK, Voulgari PV, Konitsiotis S, Argyropoulou MI, Drosos AA.

Arthritis Res Ther. 2014 Jun 17;16(3):R125. doi: 10.1186/ar4582.

46.

Lack of association of the GSDMB gene at locus 17q12 with predisposition to rheumatoid arthritis.

Chatzikyriakidou A, Voulgari PV, Drosos AA.

Clin Exp Rheumatol. 2014 May-Jun;32(3):447. Epub 2014 May 21. No abstract available.

PMID:
24848122
47.

Illness perceptions and psychological distress associated with physical health-related quality of life in primary Sjögren's syndrome compared to systemic lupus erythematosus and rheumatoid arthritis.

Kotsis K, Voulgari PV, Tsifetaki N, Drosos AA, Carvalho AF, Hyphantis T.

Rheumatol Int. 2014 Dec;34(12):1671-81. doi: 10.1007/s00296-014-3008-0. Epub 2014 Apr 27.

PMID:
24769916
48.

In transit recurrence of Merkel cell carcinoma associated with polyarthritis effectively treated with immunocryosurgery.

Voulgari PV, Gaitanis G, Markatseli TE, Kempf W, Bassukas ID.

Acta Derm Venereol. 2014 Nov;94(6):739-40. doi: 10.2340/00015555-1812. No abstract available.

49.

Effect of hydroxychloroquine on the lipid profile of patients with Sjögren syndrome.

Migkos MP, Markatseli TE, Iliou C, Voulgari PV, Drosos AA.

J Rheumatol. 2014 May;41(5):902-8. doi: 10.3899/jrheum.131156. Epub 2014 Mar 15.

PMID:
24634203
50.

Adalimumab in the treatment of rheumatoid arthritis.

Voulgari PV, Drosos AA.

Expert Opin Biol Ther. 2014 Mar 4. [Epub ahead of print]

PMID:
24588123

Supplemental Content

Loading ...
Support Center